Link to this page
Prostate Cancer Ontology
| Preferred Name | Enzalutamide | |
| Synonyms |
|
|
| Definitions |
An orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance. |
|
| ID |
http://www.semanticweb.org/ontologies/2018/1/ProstateCancer.owl#Enzalutamide_hormonal_drug |
|
| ChineseLabel |
安扎鲁胺
|
|
| definition |
An orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance.
|
|
| label |
Enzalutamide
|
|
| prefixIRI |
ProstateCancer:Enzalutamide_hormonal_drug
|
|
| prefLabel |
Enzalutamide
|
|
| reference |
NCI Thesaurus Code:C71744
|
|
| synonyms |
Enzalutamide Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl- ENZALUTAMIDE ASP9785 MDV3100 Xtandi
|
|
| URL |
https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C71744 |
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |